Transgenic expression of CD40 ligand produces an in vivo antitumor immune response against both CD40+ and CD40- plasmacytoma cells

Gianpietro Dotti, Barbara Savoldo, Patricia Yotnda, Donna Rill, Malcolm K. Brenner

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Fingerprint

Dive into the research topics of 'Transgenic expression of CD40 ligand produces an in vivo antitumor immune response against both CD40+ and CD40- plasmacytoma cells'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry